The High Cost of Access: Fact or Fiction?
Five myths about the value of the pharmaceutical distributor
To launch an orphan drug, a manufacturer must overcome unique commercialization challenges, while navigating critical product access scenarios that exist most acutely for small patient populations. Read how one manufacturer ensured that its life-changing therapy would reach patients in need the moment it was first available—and what other manufacturers can learn from this manufacturer’s experiences.
